Skip to Content
Morningstar

IQVIA Holdings Inc IQV

Morningstar Rating
Unlock
Stock XNYS Rating as of
$226.41 −0.71 (0.31%)
View Full Chart
As of Cboe BZX Real-Time Price Open
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Positive Long-Term Outlook for IQVIA as Clinical Trial Outsourcing Demand Drives Growth

Rachel Elfman

IQVIA (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, or CRO, and IMS Health, a dominant player in life sciences data and analytics. The combined company has become a leader among CROs and in the life sciences data and analytics industry. Further, as a result of the merger, the company leads in real-world evidence, in which data from sources such as patient records or medical claims can be used to create clinical evidence for regulatory approval.

Read Full Report

Price vs Fair Value

View History
IQV is trading at a 9% discount.
Price
$227.17
Fair Value
$733.00
Uncertainty
Medium
1-Star Price
$259.60
5-Star Price
$638.00
Economic Moat
Ppklh
Capital Allocation
Kcbscxbyn

Bulls Say, Bears Say

Bulls

IQVIA’s leading position in outsourced clinical trials allows it to create sticky client relationships, further honing clinical and regulatory expertise.

Bears

The company's next-generation solutions could lose traction among clients or fail to gain traction with regulatory bodies.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IQV is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$227.12
Day Range
$226.04–229.40
52-Week Range
$168.34–261.69
Bid/Ask
$226.24 / $226.48
Market Cap
$41.21 Bil
Volume/Avg
284,597 / 955,506

Key Statistics

Price/Earnings (Normalized)
22.25
Price/Sales
2.82
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
2.40%

Company Profile

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
87,000
Website
https://www.iqvia.com

Competitors

Valuation

View More
Metric
IQV
ICLR
MEDP
Price/Earnings (Normalized)
 22.2521.2245.58
Price/Book Value
 6.752.6122.27
Price/Sales
 2.822.976.83
Price/Cash Flow
 17.4218.9239.43
Price/Earnings
IQV
ICLR
MEDP

Financial Strength

Metric
IQV
ICLR
MEDP
Quick Ratio
 0.761.160.59
Current Ratio
 0.861.210.64
Interest Coverage
 3.122.99688.87
Quick Ratio
IQV
ICLR
MEDP

Profitability

Metric
IQV
ICLR
MEDP
Return on Assets (Normalized)
 7.32%6.18%20.56%
Return on Equity (Normalized)
 32.37%11.98%69.64%
Return on Invested Capital (Normalized)
 12.78%10.27%48.77%
Return on Assets
IQV
ICLR
MEDP
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Diagnostics & Research Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncRdsdhqrnbSxsj$208.9 Bil
DHR
Danaher CorpCxjnkzrfnXcwgn$175.0 Bil
IDXX
IDEXX Laboratories IncQnsqkyhkcVfgvpym$39.7 Bil
A
Agilent Technologies IncThmrzpjxkQpbvr$39.4 Bil
MTD
Mettler-Toledo International IncYcngpsbrzkPyzbyb$25.6 Bil
ICLR
Icon PLCFfbpsdbdtKzjxby$24.1 Bil
ILMN
Illumina IncRwmnjlslLsbqww$18.6 Bil
WAT
Waters CorpFgghjvjpsbDvqwk$18.0 Bil
LH
Laboratory Corp of America HoldingsXtbfgfslKnhrkq$16.8 Bil

Sponsor Center